Thompson Investment Management Inc. Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Thompson Investment Management Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 42.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,000 shares of the company’s stock after selling 3,725 shares during the quarter. Thompson Investment Management Inc.’s holdings in Henry Schein were worth $346,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of HSIC. Cromwell Holdings LLC boosted its stake in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Versant Capital Management Inc lifted its holdings in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares in the last quarter. City State Bank purchased a new stake in Henry Schein in the 4th quarter valued at about $55,000. Farther Finance Advisors LLC grew its stake in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares in the last quarter. Finally, Mather Group LLC. increased its position in shares of Henry Schein by 43.7% during the fourth quarter. Mather Group LLC. now owns 1,503 shares of the company’s stock worth $104,000 after acquiring an additional 457 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

NASDAQ HSIC opened at $79.00 on Monday. The firm’s fifty day simple moving average is $73.70 and its two-hundred day simple moving average is $71.80. The firm has a market capitalization of $9.85 billion, a P/E ratio of 32.51, a P/E/G ratio of 2.21 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63.

Analysts Set New Price Targets

Several research analysts recently issued reports on HSIC shares. Mizuho started coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Barrington Research increased their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $80.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.